P1.11-01 Cobolimab with Dostarlimab and Docetaxel in Patients with Advanced Non-small Cell Lung Cancer (NSCLC): COSTAR Lung
| Autor: | Kim, H.R., Gridelli, C., Kapur, D., Tufman, A., Felip, E., Velcheti, V., Kim, Y.J., Goetze, T.O., Lopez, P. Garrido, Corre, R., Penkov, K., Anjum, R., Di Pace, B., Liu, W., Borgovan, T., Ledger, D., Carver, J., Waszak, A., Dhar, A., Novello, S. |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology September 2022 17(9) Supplement:S109-S110 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|